Eurazeo (EPA:RF) Full Year 2024 Results
Key Financial Results
- Net loss: €429.8m (down by 124% from €1.82b profit in FY 2023).
- €5.95 loss per share (down from €25.94 profit in FY 2023).
All figures shown in the chart above are for the trailing 12 month (TTM) period
Eurazeo Revenues and Earnings Miss Expectations
Revenue missed analyst estimates by 34%. Earnings per share (EPS) was also behind analyst expectations.
Looking ahead, revenue is forecast to grow 44% p.a. on average during the next 3 years, compared to a 17% growth forecast for the Diversified Financial industry in France.
Performance of the French Diversified Financial industry.
The company's shares are down 4.5% from a week ago.
Risk Analysis
It's still necessary to consider the ever-present spectre of investment risk. We've identified 1 warning sign with Eurazeo, and understanding it should be part of your investment process.
If you're looking to trade Eurazeo, open an account with the lowest-cost platform trusted by professionals, Interactive Brokers.
With clients in over 200 countries and territories, and access to 160 markets, IBKR lets you trade stocks, options, futures, forex, bonds and funds from a single integrated account.
Enjoy no hidden fees, no account minimums, and FX conversion rates as low as 0.03%, far better than what most brokers offer.
Sponsored ContentValuation is complex, but we're here to simplify it.
Discover if Eurazeo might be undervalued or overvalued with our detailed analysis, featuring fair value estimates, potential risks, dividends, insider trades, and its financial condition.
Access Free AnalysisHave feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
About ENXTPA:RF
Eurazeo
A private equity and venture capital firm specializing in growth capital, series C, acquisitions, leveraged buyouts, and buy-ins of a private company, and investments in upper mid-market, mid-market and listed public companies, small- and mid-cap healthcare companies, equity in the small-mid and mid-large buyout segments.
Undervalued with high growth potential.
Similar Companies
Market Insights
Community Narratives
